Home/Filings/4/0001415889-25-018065
4//SEC Filing

Tsai John 4

Accession 0001415889-25-018065

CIK 0001597264other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:19 PM ET

Size

5.0 KB

Accession

0001415889-25-018065

Insider Transaction Report

Form 4
Period: 2025-06-18
Tsai John
Director
Transactions
  • Award

    Common Stock

    2025-06-18$128.12/sh+3,902$499,92412,644 total
Footnotes (1)
  • [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1
  • filerCIK 0001960467

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:19 PM ET
Size
5.0 KB